These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15078230)

  • 1. The contribution of research to Australian policy responses to heroin dependence 1990-2001: a personal retrospection.
    Hall W
    Addiction; 2004 May; 99(5):560-9. PubMed ID: 15078230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of research to the development of a national cannabis policy in Australia.
    Hall WD
    Addiction; 2008 May; 103(5):712-20. PubMed ID: 18412748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do drug policy makers access research evidence?
    Ritter A
    Int J Drug Policy; 2009 Jan; 20(1):70-5. PubMed ID: 18226519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?
    Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2007 Jan; 26(1):49-54. PubMed ID: 17364836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The costs and consequences of three policy options for reducing heroin dependency.
    Moore TJ; Ritter A; Caulkins JP
    Drug Alcohol Rev; 2007 Jul; 26(4):369-78. PubMed ID: 17564872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the initiation of heroin use after a reduction in heroin supply.
    Day C; Degenhardt L; Hall W
    Drug Alcohol Rev; 2006 Jul; 25(4):307-13. PubMed ID: 16854655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Young people with heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Mills KL; Teesson M; Darke S; Ross J; Lynskey M
    J Subst Abuse Treat; 2004 Jul; 27(1):67-73. PubMed ID: 15223096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating explanations of the Australian 'heroin shortage'.
    Degenhardt L; Reuter P; Collins L; Hall W
    Addiction; 2005 Apr; 100(4):459-69. PubMed ID: 15784060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health and politics: the demise of the ACT heroin trial.
    Wodak AD
    Med J Aust; 1997 Oct; 167(7):348-9. PubMed ID: 9379971
    [No Abstract]   [Full Text] [Related]  

  • 10. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illicit drugs and the media: models of media effects for use in drug policy research.
    Lancaster K; Hughes CE; Spicer B; Matthew-Simmons F; Dillon P
    Drug Alcohol Rev; 2011 Jul; 30(4):397-402. PubMed ID: 21355898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ACT heroin trial proposal: an overview. Australian Capital Territory.
    Bammer G; Douglas RM
    Med J Aust; 1996 Jun; 164(11):690-2. PubMed ID: 8657034
    [No Abstract]   [Full Text] [Related]  

  • 13. A tale of CIN--the Cannabis infringement notice scheme in Western Australia.
    Lenton S; Allsop S
    Addiction; 2010 May; 105(5):808-16. PubMed ID: 20331566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Federal drug law enforcement on the supply of heroin in Australia.
    Smithson M; McFadden M; Mwesigye SE
    Addiction; 2005 Aug; 100(8):1110-20. PubMed ID: 16042641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supply control does work: the case from Australia.
    Hao W
    Addiction; 2005 Jul; 100(7):926-7; discussion 930-2. PubMed ID: 15955005
    [No Abstract]   [Full Text] [Related]  

  • 16. Australian heroin seizures and the causes of the 2001 heroin shortage.
    Jiggens J
    Int J Drug Policy; 2008 Aug; 19(4):273-8. PubMed ID: 17920258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should the controlled provision of heroin be a treatment option? Australian feasibility considerations.
    Bammer G
    Addiction; 1993 Apr; 88(4):467-75. PubMed ID: 8485424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age differentials in the impacts of reduced heroin: effects of a "heroin shortage" in NSW, Australia.
    Degenhardt L; Day C; Conroy E; Gilmour S; Hall W
    Drug Alcohol Depend; 2005 Sep; 79(3):397-404. PubMed ID: 15927418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When is a little knowledge dangerous? Circumstances of recent heroin overdose and links to knowledge of overdose risk factors.
    Dietze P; Jolley D; Fry CL; Bammer G; Moore D
    Drug Alcohol Depend; 2006 Oct; 84(3):223-30. PubMed ID: 16542798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast-tracking implementation through trial design: the case of buprenorphine treatment in Victoria.
    Bammer G; Ritter A; Kutin JJ; Lintzeris N
    Aust N Z J Public Health; 2009 Feb; 33(1):34-9. PubMed ID: 19236356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.